CDC launches effort to protect cancer patients from infections

Greater attention to infection prevention is needed for vulnerable population

 

Atlanta, GA, USA (October 25, 2011) – Each year more than one million patients receive cancer treatment in an outpatient oncology clinic. Despite advances in oncology care, infections from both community and health care settings remain a major cause of hospitalization and death among cancer patients receiving chemotherapy. To help protect this vulnerable patient population, the Centers for Disease Control and Prevention is launching a new program featuring tools to help both clinicians and patients prevent infections.

 

“Cancer patients receiving chemotherapy often have weak immune systems and need to be kept safe against germs,” said CDC Director Thomas Frieden, M.D., M.P.H. “These new resources help patients take an active role in protecting themselves against infection and give doctors, nurses, and other clinicians necessary tools to better prevent infection.”

 

CDC’s Preventing Infections in Cancer Patients program is a comprehensive initiative focusing on providing information, action steps, and tools for patients, their families, and their health care providers to reduce the risk of life-threatening infections during chemotherapy treatment. These resources include an interactive website (www.preventcancerinfections.org ) for cancer patients and caregivers, as well as a Basic Infection Control and Prevention Plan for use by outpatient oncology settings.

 

The new website, called “3 Steps Toward Preventing Infections During Cancer Treatment ,” includes a questionnaire that helps cancer patients understand their risk for developing a condition called neutropenia, a low white blood cell count during chemotherapy. Neutropenia is a common and potentially dangerous side effect of chemotherapy that reduces a patient’s ability to fight infection. Cancer patients and caregivers can answer a few questions about their risk factors and receive information about how they can prepare, prevent and protect themselves from getting an infection during their cancer treatment:

 

  • Prepare: Watch out for a fever during chemotherapy.
  • Prevent: Clean your hands.
  • Protect: Know the signs and symptoms of an infection and what to do if you develop any signs or symptoms.

 

For health care providers and facility administrators, The Basic Infection Control and Prevention Plan for Outpatient Oncology Settings includes key policies and procedures to ensure the facility meets or exceeds minimal expectations for patient safety, as described in the newly released CDC Guide to Infection Prevention in Outpatient Settings. The elements in this plan are based on CDC’s evidence-based guidelines and those from professional societies.

 

“Outpatient oncology facilities’ attention to infection prevention varies greatly,” said Alice Guh, M.D., medical officer and co-lead of the initiative at CDC. “Repeated outbreaks resulting from lapses in basic infection prevention practices, such as syringe reuse, have put patients at risk. In some of these cases, the implicated clinic did not have written infection control policies and procedures or regular access to infection prevention expertise.”

 

It is critical that care of this vulnerable patient population be provided under conditions that minimize the risk of health care-associated infections. This responsibility should be shared by clinicians, to follow best practices and facility administrators, to ensure that staff has appropriate resources and training. A combined approach will help to emphasize the importance of creating a culture of infection prevention at all health care facilities.

 

The CDC recommends that outpatient oncology facilities utilize the plan in one of the following ways:

 

  • Facilities that have a plan in place should ensure that its policies and procedures include the elements outlined in this tool.
  • Facilities without a plan should use this resource as a tool to draft and implement a plan for their facility.
  • Facilities can use this plan as written or modify it with facility-specific information.

 

Preventing Infections in Cancer Patients was developed by oncology and infection prevention experts from CDC in partnership with external experts and the CDC Foundation.

 

To access the 3 Steps Toward Preventing Infections During Cancer Treatment website, please visit www.preventcancerinfections.org . To access the plan, checklist, clinician and patient education materials and additional information, please visit http://www.cdc.gov/cancer/preventinfections

 

 


Centers for Disease Control and Prevention (CDC), 25.10.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…